Esperion Therapeutics
ESPR
£1.25
Share price
-2.99%
Change (1 day)
-27.42%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) Fails to deliver data
Key failure to deliver metrics for Esperion Therapeutics:
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: £0.08 M
- Last 3 months FTD volume: £4.87 M
- Last year FTD volume: £4.87 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013
Volume in USD (price x number of shares), data since 2013Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | £3.86 M | -76.72% |
| 2024 | £16.59 M | 146.01% |
| 2023 | £6.74 M | -17.88% |
| 2022 | £8.21 M | -92.54% |
| 2021 | £0.11 B | -22.56% |
| 2020 | £0.14 B | 231.53% |
| 2019 | £42.87 M | -67.65% |
| 2018 | £0.13 B | 186.16% |
| 2017 | £46.31 M | 130.83% |
| 2016 | £20.06 M | -80.53% |
| 2015 | £0.10 B | 663.91% |
| 2014 | £13.49 M | 840.1% |
| 2013 | £1.43 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | £1.34 M | £5.53 M | 🇺🇸 USA |
 | £3.58 M | £23.49 M | 🇺🇸 USA |
 | £29.94 M | £0.34 B | 🇺🇸 USA |
 | £14.52 M | £39.95 M | 🇺🇸 USA |
 | £0.93 M | £4.96 M | 🇺🇸 USA |
 | £1.5 M | £9.7 M | 🇺🇸 USA |